Clinical Trial Update: Study of the Effectiveness and Safety of Embolization of the Middle Meningeal Artery Using Non-adhesive Materials SQUID 12 and SQUID 18 in the Treatment of Patients With Chronic Resistant Migraine [EARLY_Phase 1]

View source ↗

Summary

Phase 1 study evaluating the safety and effectiveness of embolization of the middle meningeal artery using SQUID 12 and SQUID 18 for chronic migraine. The trial…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Migraine

Drugs mentioned

• SQUID 12 (non-adhesive embolic material for middle meningeal artery embolization)
• SQUID 18 (non-adhesive embolic material for middle meningeal artery embolization)

Snippet

Sponsor: Vedanta University Clinic | Conditions: Chronic Migraine Headache | EARLY_Phase 1 | Status: RECRUITING